4D Molecular Therapeutics Reports Third Quarter 2022 Financial Results

Go back to 4D Molecular Therapeutics Reports Third Quarter 2022 Financial Results
(NASDAQ: FDMT) Delayed: 14.67 -0.24 (1.61%)
Previous Close $14.91    52 Week High
Open $14.91    52 Week Low
Day High $15.00    P/E N/A 
Day Low $14.20    EPS
Volume 1,101,308